Suresh Kumar1,
Ram Kumar Sahu2 ,
Shalini Sharma1,
Sukhbir Lal Khokra1,
Rajendra Jangde3
1Manav Bharti University, Laddo, Solan-173229 (H.P.);
2Oriental College of Pharmacy, Raisen Road, Bhopal-462021 (M.P.);
3Institute of Pharmacy, Pt. Ravi Shankar Shukla, University, Raipur (C.G.), India.
For correspondence:- Ram Sahu
Email: ramsahu79@yahoo.co.in Tel:+919893577279
Received: 20 October 2011
Accepted: 29 June 2012
Published: 16 August 2012
Citation:
Kumar S, Sahu RK, Sharma S, Khokra SL, Jangde R.
Design and Evaluation of an Oral Floating Matrix Tablet of Salbutamol Sulphate. Trop J Pharm Res 2012; 11(4):569-576
doi:
10.4314/tjpr.v11i4.7
© 2012 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Abstract
Purpose: To develop floating matrix tablets of salbutamol sulphate using ethyl cellulose and acrycoat S-100 as polymers, and sodium bicarbonate, citric acid and tartaric acid as gas generating agents.
Methods: Twenty four formulations were prepared and segregated into four major categories, A to D. The floating tablets were prepared by wet granulation technique, and the granules were compressed at a pressure of 50 kg/cm2. The tablets contained drug, ethyl cellulose and Acrycoat S-100 (as release-retarding polymers), sodium bicarbonate, citric acid and tartaric acid (as gas formers) as well as various additives. The tablets were made by wet granulation technique. The formulations were evaluated for in vitro buoyancy, dissolution and in vitro drug release.
Results: All the formulations fulfilled the essential requirements for good floating systems. Formulation F8, containing citric acid and sodium bicarbonate, showed lower lag time and longer floating duration than the formulations containing only sodium bicarbonate. Formulation F8.2 (which contained citric and tartaric acid at a ratio of 1:1) showed longer floating duration (9 h) than F8. As the concentration of sodium bicarbonate increased in formulation F8.2, drug release decreased while floating duration increased.
Conclusion: Of all the 24 formulations, the one containing tartaric acid and citric acid in ratio 1:3 and 12 mg sodium bicarbonate showed the highest floating duration and least lag time.
Keywords: Salbutamol sulphate, Ethyl cellulose, Acrycoat S-100, Sodium bicarbonate, Citric acid, Tartaric acid